LifeStance Health holder plans sale of 500,000 shares

A holder of LFST common stock has filed to potentially sell up to 500,000 shares through Fidelity Brokerage Services LLC on NASDAQ, with an aggregate market value of $5,756,737.55.

Accepted by SEC EDGAR 08/11/2026 - 05:29 PM EDT Learn about SEC filing dates

Rhea-AI Filing Summary

A holder of LFST common stock has filed to potentially sell up to 500,000 shares through Fidelity Brokerage Services LLC on NASDAQ, with an aggregate market value of $5,756,737.55. The issuer had 382,055,609 common shares outstanding. The shares to be sold include stock received as restricted stock vesting on March 6, 2025 for 82,616 shares and on March 7, 2025 for 417,384 shares, both described as compensation.

Key Figures

Planned shares to be sold: 500000 shares Aggregate market value: $5,756,737.55 Shares outstanding: 382,055,609 shares +3 more

6 metrics

Planned shares to be sold 500000 shares Maximum LFST common shares listed for sale

Aggregate market value $5,756,737.55 Value associated with 500,000 LFST shares

Shares outstanding 382,055,609 shares LFST common shares outstanding for context

Restricted stock vesting 03/06/2025 82,616 shares Compensation-related restricted stock vesting

Restricted stock vesting 03/07/2025 417,384 shares Compensation-related restricted stock vesting

Planned sale date 08/11/2026 Date associated with proposed NASDAQ sale

Key Terms

Form 144, Restricted Stock Vesting, Compensation

3 terms

Form 144 regulatory

"144: Filer Information | | | 144: Filer Information"

Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.

Restricted Stock Vesting financial

"Common | 03/06/2025 | Restricted Stock Vesting | Issuer"

Restricted stock vesting is the timetable and conditions under which shares granted to employees or insiders become fully owned and can be sold, typically requiring continued work or meeting performance goals. It matters to investors because large blocks of shares can become tradable at once, which can change share supply and price, and because vesting aligns insiders’ incentives with the company’s long‑term performance—think of it like a timed unlock that both rewards and locks in key people.

Compensation financial

"03/06/2025 | Compensation Common | 03/07/2025 |"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does the LFST Form 144 filing disclose about planned stock sales?

The filing indicates a holder may sell up to 500,000 LFST common shares on NASDAQ with an aggregate market value of $5,756,737.55. This represents a potential sale, not necessarily a completed transaction.

How many LFST shares are outstanding according to this Form 144?

The issuer reports 382,055,609 LFST common shares outstanding. This figure provides context for assessing the potential scale of the 500,000-share planned sale relative to the company’s total equity base.

What is the source of the LFST shares listed for potential sale?

The shares include stock from restricted stock vesting classified as compensation: 82,616 shares vesting on March 6, 2025, and 417,384 shares vesting on March 7, 2025.

Which broker and market are involved in the potential LFST share sale?

The potential sale of up to 500,000 LFST common shares is listed through Fidelity Brokerage Services LLC, with trades expected to occur on the NASDAQ market according to the filing details.

Does the LFST Form 144 show shares sold in the past three months?

The section for Securities Sold During The Past 3 Months appears without specific entries. The filing primarily details the planned sale and the underlying restricted stock vesting events.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001498992
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	LifeStance Health Group, Inc.
SEC File Number	001-40478
Address of Issuer	4800 N. SCOTTSDALE ROAD SUITE 2500 SCOTTSDALE ARIZONA 85251
Phone	602-767-2100
Name of Person for Whose Account the Securities are To Be Sold	Burdick Kenneth A
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Director

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Fidelity Brokerage Services LLC 900 Salem Street Smithfield RI 02917	500000	5756737.55	382055609	08/11/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	03/06/2025	Restricted Stock Vesting	Issuer			82616	03/06/2025	Compensation
Common	03/07/2025	Restricted Stock Vesting	Issuer			417384	03/07/2025	Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks
Date of Notice	08/11/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/Wade Moss, as a duly authorized representative of Fidelity Brokerage Services LLC, as attorney-in-fact for Kenneth Burdick
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)